@markjit

Modeller, epidemiologist, economist at @LSHTM, visiting prof at @HKUniversity, previously at Public Health England. Interested in vaccines, infectious diseases.

 London, UK
lshtm.ac.uk/aboutus/people/jit.mark
Joined March 2009
  • Tweets112
  • Following159
  • Followers1K
We asked a range of key decision-makers what they need to know to about potential new vaccines The results were..... Alot, and WHO's Full Value of Vaccine Assessments framework helps But FVVAs could be even more useful Our new paper gives 3 ways FVVAs could be even better:
1
6
10
1,266
Vaccines saved 154 million lives over past 50 years study in @TheLancet by @WHO & LSHTM experts estimates. @MarkJit comments on the global success of the Expanded Programme on #Immunization (EPI) 🌍💉 More 👉bit.ly/4dzKt46
"Vaccines have saved more lives than any other medical innovation in the last century, but there's still work to be done." Mark Jit, Professor of Vaccine Epidemiology, LSHTM

ALT "Vaccines have saved more lives than any other medical innovation in the last century, but there's still work to be done." Mark Jit, Professor of Vaccine Epidemiology, LSHTM

37
93
6,666
Join #EUROGIN2024 for a pivotal session on 'One-Dose Vaccination: Evidence Gaps & Global Experiences' 💉Discuss dosing plans & advances in #hpvvaccine. with @markjit & @brisson__marc ow.ly/gvIX50Qj7Zx #hpvvirus #hpvcongress #hpvawareness #cervicalcancerawareness #Eurogin
2
4
530
Mark Jit retweeted
CMMID@cmmid_lshtm15 Nov 2023
🆕 study in @GlobalHealthBMJ suggests introducing microarray patches into #immunisation programmes in LMICs could ⬇️ decrease #measles burden & prevent high treatment costs. Find out more 👇 bit.ly/3SENs32
9
1
9
2,468
Thanks to co-authors @mert0248, Edwin van Leeuwen, @VetSree, @markjit and @rozeggo! Also for a fuller understanding of the cost-effectiveness of such vaccines check out our other paper, answering similar questions in a completely different setting! bmcmedicine.biomedcentral.co…

Potential health and economic impact of paediatric vaccination using next-generation influenza...

BMC Medicine - Influenza is a major year-round cause of respiratory illness in Kenya, particularly in children under 5. Current influenza vaccines result in short-term, strain-specific immunity and...

link.springer.com
1
2
566
1) In our recent review we introduce what are economic costs and why they are used in health economic studies @Downey1L @AnnaVassall @HITAP_Thailand @markjit resource-allocation.biomedce…

What are economic costs and when should they be used in health economic studies?

Cost Effectiveness and Resource Allocation - Economic analyses of healthcare interventions are an important consideration in evidence-based policymaking. A key component of such analyses is the...

link.springer.com
1
7
22
1,897
Research by Waterlow et al. finds that next-generation vaccines may offer a cost-effective intervention to reduce influenza burden in low-income countries with year-round seasonality. @LSHTM @N_R_Waterlow Read more about this modelling study here: bmcmedicine.biomedcentral.co…
2
12
1,475
The first paper for my PhD thesis is now available at @LancetGH! 🎉 Our modelling shows that introducing new #TB #vaccines are likely to have a substantial health impact in LMICs 🗺️🦠💉 From @lshtm_tbmod @LSHTM_TB @LSHTM_Vaccines @cmmid_lshtm @LSHTM thelancet.com/journals/langl…

The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and...

Our results suggest novel tuberculosis vaccines could have substantial impact, which will vary depending on delivery strategy. Including a one-off vaccination campaign will be crucial for rapid...

thelancet.com
4
27
2
130
15,369
Replying to @Anna_Carnegie
@Anna_Carnegie and I are running a COVID-19 reflective session on the 28th of March for those involved in the UK modelling response. We hope to provide a neutral space for participants to reflect on their experiences and make suggestions to improve future outbreak responses.
1
11
14
2,920
Wondering about the science behind the shiny new WHO investment case for new TB vaccines? @AllisonPortnoy @ra_clark18 and colleagues share details in the first publication from this monumental work... @cweerasuriya @matthew_quaife @markjit @matteozignol @IAVI @
PLOS Medicine@PLOSMedicine24 Jan 2023
Allison Portnoy and colleagues explore the cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries. doi.org/10.1371/journal.pmed… @AllisonPortnoy @NickMenzies2 @richardwhite321 @decisionscience @cmmid_lshtm @WHO #tuberculosis #vaccines
10
23
2,863
Can you help with a research study on quality of life among people with and without long COVID? Or perhaps know anyone, family or friend, who could be involved in a research project? Take part on your smartphone: lshtm.ac.uk/research/centres… #research #longcovid #patientsupport
12
1
9
Mark Jit retweeted
CMMID@cmmid_lshtm15 Sep 2022
🆕 modelling study in @LancetGH looks at feasibility of eradicating #rubella & #measles by evaluating several #vaccination scenarios. ✍️ Amy Winter (@PublicHealthUGA) | @markjit | @petrakle | @Shaun_Truelove | & others from @ramboll, @CDCgov & more ➡️ bit.ly/3UlvT6L
7
15
I wrote a #NaturePortfolioCommunities "Behind the Paper" blog post which provides a (hopefully accessible!) introduction to my recent @NatureComms paper w/ @_nickdavies @markjit @cmmid_lshtm & John Edmunds ⬇️ healthcommunity.nature.com/p… *bonus content included, details below* 🎁
3
15
1
32
Want to know the impact and cost-effectiveness of COVID-19 vaccination across Africa? And the cost of delay? New evidence from the health economics program at Africa CDC collaborating with LSHTM @yangliubeijing @markjit @mert0248 and CGD IDSI colleagues @idsihealth
Justice Nonvignon@just_nonvignon10 May 2022
Excited to share this policy brief showcasing evidence to support scaling up #COVID19 Vaccination in Africa - earlier start and speed of delivery matter @AfricaCDC @CGDev @idsihealth @HERU_KEMRI_WT @LSHTM_GHECO @EdwineBarasa @AnnaVassall @JavierHGuzmanC @glassmanamanda
4
18
Mark Jit retweeted
CMMID@cmmid_lshtm10 Mar 2022
🆕 paper on @BMCMedicine from @cmmid_lshtm members Kaja Abbas, @petrakle, @markjit. 💉 The study looks at the impact of vaccination on #measles mortality, where case fatality ratios are a function of dynamically changing measles incidence. ➡️ bit.ly/3J1hCGf

Differential health impact of intervention programs for time-varying disease risk: a measles...

BMC Medicine - Dynamic modeling is commonly used to evaluate direct and indirect effects of interventions on infectious disease incidence. The risk of secondary outcomes (e.g., death) attributable...

link.springer.com
1
3
2020 saw an unexpected decline in dengue cases. Here we link this to specific COVID-19 movement restrictions and estimate they averted 720,000 cases. Will have a considerable (+/-?) impact on future dengue dynamics and hints at new control strategies doi.org/10.1016/S1473-3099(2…
3
57
5
173
We're now in the third year of the SARS-CoV-2 pandemic. How should we think about Covid-19 travel restrictions in the era of vaccines and variants? A new comment piece in The Lancet led by @AdamJKucharski thelancet.com/journals/lance…
2
3
8
Different strains of influenza exhibit different seasonal patterns by latitude across mainland China in this analysis led by Charlie Diamond and colleagues from @cmmid_lshtm @LSHTM and @FudanUniv: bmcmedicine.biomedcentral.co…
1
4
1
11
#HKUSPH Dr @kathysleung, Prof @markjit, Prof @gmleunghku & Prof @jtkwu assessed the effectiveness of #COVID19 vaccines & antivirals in exit strategies for #AsiaPacific ▶Key message: Increasing vax coverage is the most important Paper out @LancetRH_WPac: bit.ly/3rG2qYw
2
2
The work is now out at @LancetRH_WPac: sciencedirect.com/science/ar…. Though it was done before the emergence of Omicron, we hope it would help design the exit strategies for the Asia Pacific region. Many thanks to @markjit @jtkwu
Mark Jit@markjit21 Oct 2021
Our work led by @kathysleung looking at the role of vaccines and antivirals in exit strategies in places that saw relatively little Covid (until recently for some). Not peer reviewed yet.
1
2
Load more